- Johnson & Johnson to pay $5.5bn settlement over baby powder lawsuits The Independent —
- Johnson & Johnson settles US talcum powder lawsuit with $5.5bn payout Financial Times —
- Johnson & Johnson Agrees to Pay $5.5 Billion to Settle Talc Lawsuits Wall Street Journal —
- Johnson & Johnson offers $5.5 bn to settle talc lawsuits IOL —
- Johnson & Johnson to pay $5.5 billion to settle talc-related cancer claims Business Standard —
- Johnson & Johnson reaches proposed $5.5B settlement to resolve talc lawsuits tied to ovarian cancer claims Anadolu Agency —
- Johnson & Johnson reaches proposed $5.5B talcum powder settlement UPI —
- J&J announces $5.5 billion settlement of talc lawsuits RTE —
- J&J offers $5.5bn settlement in lawsuits claiming talc link to cancer Al Jazeera —
- Johnson & Johnson offers $5.5 billion to settle talc lawsuits CBS News —
- Johnson & Johnson offers up to $5.5bn to settle baby powder lawsuits MyJoyOnline —
- Johnson & Johnson offers up to $5.5bn to settle baby powder lawsuits BBC News —
J&J Proposes $5.5bn Talc Settlement
The $5.5 billion proposal aims to resolve over 60,000 claims from women who alleged that J&J's talc-based powders contained asbestos and caused ovarian cancer.
The company has consistently denied the allegations, but previous settlement attempts failed.
This new offer comes after a series of court setbacks and is structured to gain broad claimant support.
The deal would allow J&J to move past the litigation without admitting liability.
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
United States
Country located primarily in North America
Country located primarily in North America
Ovarian cancer
Female reproductive organ cancer that is located in the ovary
Female reproductive organ cancer that is located in the ovary